ProteoSeine-Institut Jacques Monod

Research organisation

ProteoSeine-Institut Jacques Monod

Description

ProteoSeine is the proteomics platform of the Institut Jacques Monod, UMR 7592 Université de Paris Cité - CNRS. Since early 2009, it has been located in the Buffon building at 15 rue Hélène Brion, 75205 Paris CEDEX 13 - France. The platform's activities include analytical services, technical and methodological research and development, and active technology monitoring. In this context, it uses state-of-the-art mass spectrometry approaches to study the protein components of living systems.

ProteoSeine-Institut Jacques Monod

Address

Institut Jacques Monod, 15 rue Hélène Brion
75205 PARIS, France

Contact

guillaume.chevreux@ijm.fr

Description

ProteoSeine is the proteomics platform of the Institut Jacques Monod, UMR 7592 Université de Paris Cité - CNRS. Since early 2009, it has been located in the Buffon building at 15 rue Hélène Brion, 75205 Paris CEDEX 13 - France. The platform's activities include analytical services, technical and methodological research and development, and active technology monitoring. In this context, it uses state-of-the-art mass spectrometry approaches to study the protein components of living systems.

Matchmaking

Connect with ProteoSeine-Institut Jacques Monod

This entity is yours?

Update information

Position on the value chain

With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.

Bio-resources and biobanking
  • Cells, tissues and humanized xeno-organs
  • Biosamples
  • Viral, phage or bacterial specimen
Identification of biotherapies
  • Target identification
  • Target validation
  • Screening
Drug design
  • Drug assessment
  • Drug engineering
  • In vitro preclinical studies
Clinical validation
  • Clinical trials
  • In vivo preclinical validation
  • Pre-industrial scale production
Production
  • Upstream processes
  • Downstream processes
  • Quality control
Market access
  • CE mark / market authorisation
  • Payment / Reimbursement
  • Care pathways